Arcturus Therapeutics (ARCT) P/E (2019 - 2026)
Arcturus Therapeutics (ARCT) P/E from Jul 1, 2019 to Jul 21, 2026. The TTM Arcturus Therapeutics (ARCT) P/E is -2.14. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Arcturus Therapeutics (ARCT)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.14 | -17.24% |
| 2025 | -2.58 | -54.56% |
| 2024 | -5.68 | -167.48% |
| 2023 | 8.42 | -375.49% |
| 2022 | -3.06 | -36.16% |
| 2021 | -4.79 | -64.82% |
| 2020 | -13.60 | +58.83% |
| 2019 | -8.57 | N/A |
Comparison Arcturus Therapeutics (ARCT) P/E with competitors
Arcturus Therapeutics (ARCT) P/E is -2.14.